Your browser doesn't support javascript.
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.
Cevik, Muge; Grubaugh, Nathan D; Iwasaki, Akiko; Openshaw, Peter.
  • Cevik M; Division of Infection and Global Health, School of Medicine, University of St Andrews, Fife, UK. Electronic address: mc349@st-andrews.ac.uk.
  • Grubaugh ND; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA; Yale Institute for Global Health, Yale University, New Haven, CT, USA.
  • Iwasaki A; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
  • Openshaw P; National Heart and Lung Institute, Imperial College London, London, UK.
Cell ; 184(20): 5077-5081, 2021 09 30.
Article in English | MEDLINE | ID: covidwho-1474390
ABSTRACT
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible variants, such as Delta, also raised concerns about the effectiveness provided by current vaccines. Understanding immunological correlates of protection and how laboratory findings correspond to clinical effectiveness is imperative to shape future vaccination strategies.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Pandemics / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Cell Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / Pandemics / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Limits: Humans Language: English Journal: Cell Year: 2021 Document Type: Article